The first meeting of the AMCHAM’s Pharmaceutical Committee was held virtually on August 26th under the leadership of Mr. Umang Chaturvedi, Chairman – Pharmaceutical Committee, AMCHAM and Head of Policy & International Affairs, Mylan and Ms. Jyotsna Ghosal, Co-Chairperson – Pharmaceutical Committee, AMCHAM and Executive Director – Corporate Communications, Johnson and Johnson. Senior healthcare experts from Baxter, Eli Lilly, Honeywell India, Corning Technologies, IFF, Deloitte, Par Formulations, Dua Associates, APCO Worldwide and Paraxel participated. It was decided that going forward, the committee would focus on select policy and regulatory issues. Some of the priority issues highlighted by members included market access issues – PPO and TMR, regulatory barriers and IP burden. In addition, the committee would be strongly taking up policy advocacy with relevant stakeholders and have engagements with state governments.